NCT04677478

Brief Summary

The respiratory isolation could have a harmful impact on the well-being of patients, especially in a psychological point of view such as anxiety and depression disorders or through the relationship with medical team and/or relatives but also in terms of informations. The evaluation of the impact of respiratory isolation in patients hospitalized for tuberculosis or COVID-19 could allow to identify the different kinds of problems encountered by these patients (physical, psychological, sociological, informations, ...) in order to adapt the environment for efficient care and to improve patient's well-being. The purpose of this research is to evaluate the psychological impact of the respiratory isolation on the quality of life in patients hospitalized for tuberculosis or COVID-19.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

December 21, 2020

Status Verified

December 1, 2020

Enrollment Period

1.1 years

First QC Date

December 15, 2020

Last Update Submit

December 18, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Quality of life using semi-structured interview.

    Quality of life will be assessed using semi-structured interview.

    at 28 days respiratory isolation

  • Quality of life using 36-Item Short Form Health Survey (SF-36)

    Quality of life will be assessed using SF-36. SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting. Items are grouped into three categories: functional status, well-being, overall health assessment. The scores for the different items are coded and then summed and transformed linearly on a scale ranging from 0 to 100.

    at 28 days respiratory isolation

  • Quality of life using State-Trait Anxiety Inventory (STAY) A+B scale

    The State-Trait Anxiety Inventory is a self-rated scale. Each type of anxiety has its own scale of 20 different questions that are scored. STAY-YA and STAY-YB Scores range from 20 to 80. A higher score is higher anxiety.

    at 28 days respiratory isolation

  • Quality of life using Beck Depressive Inventory (BDI) -13

    It is a self-rated scale. each item is made up of 4 sentences corresponding to 4 degrees of intensity of increase in a symptom: from 0 to 3. The overall score is obtained by adding the scores of the 13 items. The range of the scale is 0 to 39.

    at 28 days respiratory isolation

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients treated for tuberculosis or COVID-19 and placed in respiratory isolation.

You may qualify if:

  • Patient who are more than 18 years old hospitalized in respiratory isolation for tuberculosis or COVID-19.
  • Patient able to understand questions and to communicate verbally with investigators.
  • Patient who has given his consent.

You may not qualify if:

  • Patient deprived of their rights
  • Patient under tutorship or guardianship or under the protection of a conservator
  • Tuberculosis without respiratory isolation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

TuberculosisCOVID-19

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsPneumonia, ViralPneumoniaRespiratory Tract InfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2020

First Posted

December 21, 2020

Study Start

December 1, 2020

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

December 21, 2020

Record last verified: 2020-12